Depending on the study's results, it's possible that anal health will become a routine conversation topic between doctors and patients -- and labs won't think twice when they receive a pap smear specimen from a man.
Shouldn't we immediately ramp up access to HAART for everyone in the world who needs it? Of course we should. However, that's easier said than done. Providing universal ARV therapy globally will be expensive.